A Systematic Review and Meta-Analysis of the Incidence Rate of Major Adverse Kidney Events Following COVID-19 Infection
Research in Clinical Pharmacy · 2024
DOI: 10.59931/rcp.24.0005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Research in Clinical Pharmacy, 2024. Verfasst von Vivian Sum Yee Lam und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This systematic review and meta-analysis investigated the incidence of major adverse kidney events (MAKE) in patients following COVID-19 infection.A comprehensive literature search was conducted using PubMed, Embase, Cochrane Library, and CINAHL databases from their inception to July 18, 2022.Eleven studies met the inclusion criteria.The methodological quality of each study was evaluated using the modified Leboeuf-Yde and Lauritsen tool.Random-effects meta-analysis revealed a pooled MAKE incidence of 6.16 per 100 persons (95% CI: 3.01-12.21).Death had an incidence of 4.28 (95% CI: 2.18-8.26),kidney failure had an incidence of 1.49 (95% CI: 0.27-7.77),initiation of renal replacement therapy had an incidence of 3.54 (95% CI: 0.00-98.43),and worsening of renal function tests had an incidence of 21.82 (95% CI: 0.05-99.42).The analyses revealed high heterogeneity among the pooled data, with I 2 values ranging from 88.5-99.8%.Begg's funnel plot indicated the absence of publication bias.The overall findings suggest that the incidence of MAKE following COVID-19 infection in the general population is higher than expected, highlighting the importance of monitoring kidney disease during postacute care.Notably, the extreme heterogeneity observed in the data and limited number of studies included in the analysis warrant further research to determine the occurrence of MAKE after COVID-19 infection in different geographical regions and to compare risk with appropriate controls.
Zitieren
APA
Lam, V. S. Y., Chan, K., Liang, J., & Cheng, F. W. (2024). A Systematic Review and Meta-Analysis of the Incidence Rate of Major Adverse Kidney Events Following COVID-19 Infection. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.24.0005
Vancouver
Lam VSY, Chan K, Liang J, Cheng FW. A Systematic Review and Meta-Analysis of the Incidence Rate of Major Adverse Kidney Events Following COVID-19 Infection. Research in Clinical Pharmacy. 2024. doi:10.59931/rcp.24.0005
BibTeX
@article{Lam2024,
author = {Lam, Vivian Sum Yee and Chan, Kyton and Liang, Jiahao and Cheng, Franco Wing-Tak},
title = {A Systematic Review and Meta-Analysis of the Incidence Rate of Major Adverse Kidney Events Following COVID-19 Infection},
journal = {Research in Clinical Pharmacy},
year = {2024},
doi = {10.59931/rcp.24.0005}
}
EUVIMED